We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
Read MoreHide Full Article
Molina Healthcare, Inc. (MOH - Free Report) has been in investors’ good books, riding on solid third-quarter results and restructuring initiatives.
It retained investors' bullish sentiments by maintaining its beat streak in all the last four quarters, the average being 14.8%. This, in turn, underlines its operational excellence.
Its return on equity — a profitability measure — is 43.2%, better than the industry average of 24.5%. The metric reflects the company’s effectiveness in utilizing its shareholders’ money, which impresses investors.
The company gained from higher admissions in the third-quarter, which added to its overall performance. Its membership increased 20.5% in the first nine months of 2020. We expect the same to rise on the back of contract wins and strategic initiatives.
Following the stellar results, the company reaffirmed its outlook for the current year, which should instill investor’s confidence in the stock. It still expects earnings in the range of $11.20-$11.70 per share. However, it raised its 2020 total revenue outlook to $19.6 billion, up from its prior projection of $18.8 billion. This was owing to the Passport buyout in Kentucky and the novation of the entity’s Medicaid contract to Molina Healthcare on Sep 1.Its core performance is anticipated to stay solid through the fourth quarter of 2020.
Over the past several years, the company has been witnessing growing revenues on the back of its strategic initiatives and membership growth. In the first nine months of 2020, the top line increased 13% year over year. We are hopeful that the metric will continue growing on its strategic initiatives and higher memberships.
Molina Healthcare has also been gaining traction from its restructuring and profitability improvement plan, which started in 2017. The plan included streamlining of organizational structure to improve efficiency as well as the speed and quality of decision-making. We expect this initiative to help curb costs going forward.
The leading health insurance giant has been partnering with companies as well as acquiring units to expand its presence. It entered into an agreement to acquire the Magellan Complete Care (MCC) line of business of Magellan Health, Inc. for a total deal value of $820 million. The transaction will serve more than 3.6 million members under the government-sponsored healthcare programs across 18 states. With this addition, the company is expected to build a better portfolio and gain an enhanced geographic diversity. The company also inked a deal to buy substantially all the assets of Affinity Health Plan, Inc. in September 2020. All these initiatives bode well for the long haul.
Its earnings estimate for 2020 stands at $12.56, suggesting an upside of 8.6% from the prior-year reported figure.
Other companies in the same space, such as UnitedHealth Group Incorporated (UNH - Free Report) , Centene Corporation (CNC - Free Report) and Anthem Inc. have also gained 30.7%, 14% and 13.3% in the same time frame.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration. Download Marijuana Moneymakers FREE >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
Molina Healthcare, Inc. (MOH - Free Report) has been in investors’ good books, riding on solid third-quarter results and restructuring initiatives.
It retained investors' bullish sentiments by maintaining its beat streak in all the last four quarters, the average being 14.8%. This, in turn, underlines its operational excellence.
Its return on equity — a profitability measure — is 43.2%, better than the industry average of 24.5%. The metric reflects the company’s effectiveness in utilizing its shareholders’ money, which impresses investors.
The company gained from higher admissions in the third-quarter, which added to its overall performance. Its membership increased 20.5% in the first nine months of 2020. We expect the same to rise on the back of contract wins and strategic initiatives.
Following the stellar results, the company reaffirmed its outlook for the current year, which should instill investor’s confidence in the stock. It still expects earnings in the range of $11.20-$11.70 per share. However, it raised its 2020 total revenue outlook to $19.6 billion, up from its prior projection of $18.8 billion. This was owing to the Passport buyout in Kentucky and the novation of the entity’s Medicaid contract to Molina Healthcare on Sep 1.Its core performance is anticipated to stay solid through the fourth quarter of 2020.
Over the past several years, the company has been witnessing growing revenues on the back of its strategic initiatives and membership growth. In the first nine months of 2020, the top line increased 13% year over year. We are hopeful that the metric will continue growing on its strategic initiatives and higher memberships.
Molina Healthcare has also been gaining traction from its restructuring and profitability improvement plan, which started in 2017. The plan included streamlining of organizational structure to improve efficiency as well as the speed and quality of decision-making. We expect this initiative to help curb costs going forward.
The leading health insurance giant has been partnering with companies as well as acquiring units to expand its presence. It entered into an agreement to acquire the Magellan Complete Care (MCC) line of business of Magellan Health, Inc. for a total deal value of $820 million. The transaction will serve more than 3.6 million members under the government-sponsored healthcare programs across 18 states. With this addition, the company is expected to build a better portfolio and gain an enhanced geographic diversity. The company also inked a deal to buy substantially all the assets of Affinity Health Plan, Inc. in September 2020.
All these initiatives bode well for the long haul.
Its earnings estimate for 2020 stands at $12.56, suggesting an upside of 8.6% from the prior-year reported figure.
Zacks Rank and Price Performance
Shares of this currently Zacks Rank #2 (Buy) company have surged 62.7% in a year’s time, outperforming its industry’s growth of 19%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other companies in the same space, such as UnitedHealth Group Incorporated (UNH - Free Report) , Centene Corporation (CNC - Free Report) and Anthem Inc. have also gained 30.7%, 14% and 13.3% in the same time frame.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>